These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33724653)

  • 1. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
    Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
    Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
    Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
    Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes.
    Yen HH; Chen PY; Huang RY; Jeng JM; Lai IR
    J Pathol Clin Res; 2024 Jul; 10(4):e12387. PubMed ID: 38860888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
    Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
    Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
    Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
    Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.
    Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer.
    Nakamura K; Eto K; Iwagami S; Ogawa K; Sawayama H; Ishimoto T; Iwatsuki M; Baba Y; Miyamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2022 Mar; 27(3):512-519. PubMed ID: 35084597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
    Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
    Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC).
    Liu YJ; Ye QW; Li JP; Bai L; Zhang W; Wang SS; Zou X
    Sci Rep; 2024 Sep; 14(1):22596. PubMed ID: 39349535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profile of poorly cohesive gastric carcinoma with special reference to survival.
    Koseki Y; Hatakeyama K; Terashima M; Nagashima T; Urakami K; Ohshima K; Aizawa D; Sugino T; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Okamura Y; Akiyama Y; Yamaguchi K
    Gastric Cancer; 2023 Jul; 26(4):553-564. PubMed ID: 37036539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
    Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
    Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.
    Shi W; Wang Y; Xu C; Li Y; Ge S; Bai B; Zhang K; Wang Y; Zheng N; Wang J; Wang S; Ji G; Li J; Nie Y; Liang W; Wu X; Cui J; Wang Y; Chen L; Zhao Q; Shen L; He F; Qin J; Ding C
    Nat Commun; 2023 Feb; 14(1):835. PubMed ID: 36788224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.
    Yorita N; Ito M; Boda T; Kotachi T; Nagasaki N; Abuduwaili M; Hata K; Hiyama Y; Oka S; Yoshihara M; Kitadai Y; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1955-1962. PubMed ID: 31062875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.
    Mariette C; Carneiro F; Grabsch HI; van der Post RS; Allum W; de Manzoni G;
    Gastric Cancer; 2019 Jan; 22(1):1-9. PubMed ID: 30167905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
    Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
    World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.